Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anas Mady"'
Autor:
Basheer, Abdulrahman, Ahmed, Mady, Mohammad Al, Odat, Ashraf Al, Tayar, Muhammad Asim, Rana, Abdulrahman, Alharthy, Alyaa, Alhazmi, Ahmed S, Abdelmoaty, Muhammad Mansoor, Hafeez, Ahmed, Kuhail, Alfateh M, Noor, Mohammed, Haddad, Anas, Mady, Noor, Ali, Huda, Mhawish, Waleed, Aletreby
Publikováno v:
Journal of Ayub Medical College Abbottabad. 34:397-402
Background: Corona virus disease is caused by the enveloped, single stranded RNA virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) becoming the deadliest disease of the century. Its global outbreak has led researchers to dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::068c6f9c3847ce140d88c7b8d41dad83
https://doi.org/10.55519/jamc-03-10305
https://doi.org/10.55519/jamc-03-10305
Autor:
Alyaa Elhazmi, Saad M Altamimi, Noor Monther Ali, Anas Mady, Sajedah Almarzooq, Ahmed Mady, Abdulrahman Alharthy, Rehab Eltreafi, Arwa Alotaibi, Basheer Abdulrahman, Shahzad Ahmad, Ali S. Omrani, Waleed Tharwat
Publikováno v:
Pakistan Journal of Medical and Health Sciences. 15:2848-2852
Background: Colistin is an effective treatment option, recommended for carbapenem resistant gram-negative bacilli (CR-GNB) in critically ill patients. Due to high nephrotoxicity, dose management of Colistin is a tough decision to make. At standard do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::004c8ddc5cdf97a2e1efc6ab54ce526e
https://doi.org/10.53350/pjmhs2115102848
https://doi.org/10.53350/pjmhs2115102848
Autor:
Anas Mady, Mohammad Al Odat, Waqas Mahmood, Faisal Alshammary, Huda Mhawish, Ahmed Mady, Lamia A Alzaaqi, Batulk Nassan, Basheer Abdulrahman, Hawra H Albayat, Waleed Tharwat, Saima Akhtar, Rahaf Felemban
Publikováno v:
Pakistan Journal of Medical and Health Sciences. 15:2838-2840
Background: Over the past decade, excessive use of Colistin against multidrug-resistant, Gram-negative bacteria have resulted in the evolution of resistance to Colistin. Objective: To evaluate efficacy of Colistin against multidrug-resistant organism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b52eacc7b539772089806ac0d5af8685
https://doi.org/10.53350/pjmhs2115102838
https://doi.org/10.53350/pjmhs2115102838